In different, phylogenetically unrelated micro-organisms, glycolytic enzymes play a dual role. In the cytosol they are involved in metabolic reactions whereas the surface-localized fraction of the enzymes contributes to adhesion and virulence. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a typical member of this group of multifunctional proteins. In this study, we characterized the GAPDH of Mycoplasma pneumoniae, a common pathogen of the human respiratory mucosa. Full-length GAPDH of M. pneumoniae was successfully expressed and used to produce a polyclonal antiserum. By immunofluorescence, colony blot and ELISA experiments with different fractions of the M. pneumoniae proteins, GAPDH was demonstrated to be present in the cytosol and at even higher concentrations at the surface of mycoplasmas. Nevertheless, antibodies against recombinant GAPDH were not detected in sera of immunized animals or of patients with confirmed M. pneumoniae infection. Recombinant GAPDH bound to different human cell lines in a concentration-dependent manner, and binding was inhibited by specific anti-GAPDH serum. In contrast, this antiserum did not significantly influence the adherence of M. pneumoniae to HeLa cells. When different human extracellular matrix proteins were tested in Western blot assays, GAPDH bound to fibrinogen. The results showed that the GAPDH of M. pneumoniae is a member of the family of cytosol-localized glycolytic enzymes, which also occur at the surface of the bacterium, and mediates interactions with the extracellular matrix proteins of the human host. Thus, the surface-exposed fraction of GAPDH may be a factor that contributes to the successful colonization of the human respiratory tract by M. pneumoniae.
INTRODUCTION
The cell wall-less bacterium Mycoplasma pneumoniae is an obligate pathogen of the human respiratory tract causing a wide range of different infections. Between 3 and 30 % of all cases of community-acquired pneumonia can be attributed to this micro-organism (Waites & Talkington, 2004) . M. pneumoniae mainly infects older children and young adults but recent studies have shown that all age groups can be affected (von Baum et al., 2009) . Infections occur endemically in closed populations such as army camps (Klement et al., 2006) , but worldwide epidemic peaks at intervals of 3-7 years have been documented (Lind et al., 1997; Eun et al. 2008) . Furthermore, respiratory infections can be followed by extra-pulmonary manifestations, causing neurological, gastrointestinal, cardiovascular, haematological and dermatological disorders (Narita, 2010) .
Despite the reduced genetic repertoire of 814 kb and the limited metabolic pathways (Himmelreich et al., 1996; Dandekar et al., 2000) , M. pneumoniae is perfectly adapted to interaction with the human respiratory mucosa, which is the only known infection site. The unique tip structure (attachment organelle) of these mycoplasmas comprises a complex network of adhesins and adherence-associated proteins that mediate the directed adhesion of the bacteria to the epithelial cells (Krause & Balish, 2004) . The formation of superoxide radicals and the expression of the pertussis-like CARDS cytotoxin (Kannan & Baseman, 2006) were shown to disrupt the integrity of the respiratory epithelium.
In recent years many reports have been published confirming the role of different glycolytic enzymes of bacteria, fungi and parasites as adhesion/virulence factors in a broader sense (Pancholi & Chhatwal, 2003) . Besides their glycolytic activity in the cytosol, these enzymes have been found at the surface of micro-organisms, where they act as binding partners of proteins of the human extracellular matrix (ECM). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH; EC 1.2.1.12), which catalyses the conversion of glyceraldehyde 3-phosphate to 1,3-diphosphoglycerate, is a typical enzyme belonging to this class of proteins with multiple functions. Extracellular localization of GAPDH has been confirmed for an increasing number of micro-organisms, including Streptococcus species, Staphylococcus species, Lactobacillus plantarum, Neisseria meningitidis, Escherichia coli, Paracoccidioides brasiliensis, Trichomonas vaginalis and Candida albicans. As a surface-associated protein, GAPDH can interact with not only one or more specified host factors like fibronectin, fibrinogen, albumin, laminin, collagen and plasminogen but also human colonic mucin, human epithelial and endothelial cells or fimbriae of other bacterial species in biofilms (Pancholi & Fischetti, 1992; Gozalbo et al., 1998; Bergmann et al., 2004; Barbosa et al., 2006; Egea et al., 2007; Kinoshita et al., 2008; Nagata et al., 2009; Purves et al., 2010; Tunio et al., 2010a) .
Previous studies have confirmed that the described biological function of glycolytic enzymes, in addition to their metabolic role, can also be found in members of the class Mollicutes. Elongation factor Tu and pyruvate dehydrogenase E1 b subunit are located at the surface of M. pneumoniae and were described as binding human fibronectin (Dallo et al., 2002) . In the uropathogenic species Mycoplasma genitalium, which shares high homology with M. pneumoniae (Herrmann & Reiner, 1998) , GAPDH was found to be surface-exposed and mediated binding to human mucin (Alvarez et al., 2003) . The a-enolase of Mycoplasma fermentans, which also occurs in the human urogenital tract, is involved in the adherence of the bacteria to HeLa cells and acts as binding protein to human plasminogen (Yavlovich et al., 2007) . The surfaceassociated protein MSG1 of the haemotrophic mycoplasma species Mycoplasma suis has been identified as GAPDH and contributes to the adhesion of the micro-organisms to erythrocytes (Hoelzle et al., 2007) . In contrast, in the avian pathogen Mycoplasma gallisepticum, two non-glycolytic, cytadherence-associated proteins were found to act as binding partners of fibronectin (May et al., 2006) . It should be noted that the GAPDH gene in mollicutes can show a high level of recombination as confirmed in Mycoplasma hominis (Søgaard et al., 2002) .
Little is known about the GAPDH of M. pneumoniae. Besides the binding to human mucin of GAPDH of the closely related species M. genitalium, no other interactions of GAPDH of either species with human ECM proteins have been described. Furthermore, experimental data on elongation factor Tu showed that minor amino acid changes will influence the binding to human ECM proteins (Balasubramanian et al., 2009) , and investigation of the M. pneumoniae-specific protein is required to permit detailed conclusions. The aim of this study was to characterize the GAPDH of M. pneumoniae in order to contribute to the understanding of the role of this enzyme in the pathogenesis of infections.
METHODS
Mycoplasma strains, cell lines and culture conditions. The M. pneumoniae strains M129 (ATCC 29342, subtype 1), FH (ATCC 15531, subtype 2) and the patient isolates 3896 (subtype 3), 4817 (variant 1) and ST (variant 2a) were grown in 50 ml PPLO medium (Becton Dickinson) supplemented with 20 % heat-inactivated horse serum (Gibco), 0.15 % yeast extract (Becton Dickinson) and 0.1 % glucose (Merck) in 75 cm 2 tissue culture flasks (Greiner) at 37 uC (Dumke et al., 2003) . After a slight colour change of the medium from red to orange, the mycoplasmas attached to the bottom were washed twice with room temperature PBS (8.8 g NaCl, 1.6 g Na 2 HPO 4 , 0.2 g NaH 2 PO 4 , per litre) and finally scraped off into the same buffer. Bacteria were pelleted by centrifugation at 3345 g for 15 min and resuspended in 1 ml PBS.
HeLa cells (human cervical carcinoma cell line, ATCC CCL-2) were cultured as described by Schurwanz et al. (2009) in tissue culture flasks containing DMEM medium (Gibco) supplemented with 10 % fetal calf serum (FCS; Invitrogen). Primary human bronchial epithelial cells (Hbe; PromoCell) were grown in Airway Epithelium Medium (PromoCell) according to the manufacturer's recommendations. Cells were detached using accutase (PAA Laboratories) immediately prior to adhesion inhibition assay (HeLa) or passaging.
DNA extraction, amplification of mpn430 gene coding for GAPDH, expression and purification of recombinant M. pneumoniae GAPDH. DNA was isolated from harvested M. pneumoniae strains using the QIAamp DNA mini kit (Qiagen) according to the manufacturer's instructions. Standard PCR with primers MPgapf and MPgapr (Table 1) amplified the genome region surrounding the GAPDH encoding gene (mpn430), which was sequenced in the five M. pneumoniae strains. The PCR product of strain M129 was used as target for the multiple mutation reaction (MMR) to change the single TGA codon in the GAPDH gene (position 268-270) to TGG by using the primers MPgapVf and MPgapVr to create vector-specific overhangs, the mutation primer MPgapM and Pfu polymerase (Fermentas) as described by Hames et al. (2005) .
The PCR product of the MMR was cloned into the pET-30/LIC vector with the ligation independent cloning kit (Novagen) as recommended by the manufacturer. Transformation of Escherichia coli NovaBlue and BL21(DE3), sequencing of the insert, expression, purification and concentration of the N-terminal 66His-tagged recombinant protein were performed as described in a recent study (Schurwanz et al., 2009) . The protein concentration was determined by BCA protein assay (Pierce).
Generation of polyclonal antiserum against M. pneumoniae GAPDH. The recombinant GAPDH was diluted to a concentration of 100 mg in 200 ml PBS and mixed with 100 ml complete Freund's adjuvant (Sigma). Primary subcutaneous immunization of a male guinea pig (Charles River), booster immunizations and the collection of serum were carried out as described by Schurwanz et al. (2009) . Serum was aliquoted and stored at 220 uC until use.
To remove antibodies against the remaining E. coli BL21(DE3) proteins in the antigen preparation, the anti-GAPDH serum was incubated overnight at 4 uC with sonicated and immobilized E. coli BL21(DE3) whole-cell extract as described by Proft & Herrmann (1994) . ELISA experiments resulted in A 450 ,0.4 after reaction of the purified antiserum with whole cell E. coli BL21(DE3) preparations without influencing the reactivity to M. pneumoniae whole cells (data not shown).
SDS-PAGE and Western blotting.
To confirm the quality of recombinant protein expression, the eluted fractions (pH 5.4 and 4.9) were analysed by SDS-PAGE using 10 % NuPage Bis-Tris gels IP: 54.70.40.11
On: Thu, 10 Jan 2019 16:18:11 (Invitrogen) and Coomassie staining (Merck). For immunoblotting, the separated protein fractions were transferred to nitrocellulose membranes (Invitrogen) by using standard procedures. The recombinant protein was detected by an anti-His-tag monoclonal antibody (1 : 500; Sigma) and peroxidase-conjugated anti-mouse immunoglobulin IgG (1 : 1000; Pierce). To confirm the specificity of the anti-GAPDH serum, blotted recombinant GAPDH was incubated with the polyclonal antiserum (1 : 500) and detected with anti-guinea pig IgG (1 : 1000; Sigma). Hyperimmune sera (1 : 100) of guinea pigs infected three times intranasally with freshly grown M. pneumoniae or immunized three times subcutaneously with M. pneumoniae whole cells were added to blotted recombinant protein to detect specific antibodies against recombinant GAPDH. Furthermore, sera (1 : 100) of patients with serologically confirmed M. pneumoniae infections showing high titres of specific IgM and/or IgA immunoglobulins as measured by commercial ELISA and Western blot assays (Virotech) were used to prove the occurrence of a specific GAPDH response in the natural host. Detection was carried out with anti-human Ig (1 : 500; Dako). A possible cross-reaction of recombinant GAPDH with human GAPDH was tested after incubation with rabbit anti-human GAPDH (1 : 200; Sigma) and detection with anti-rabbit IgG (1 : 500; Dako).
The reaction of the antiserum raised against recombinant GAPDH of M. pneumoniae with M. pneumoniae M129 was analysed by incubating blotted whole cell preparations (50 mg) with this polyclonal guinea pig serum (1 : 200). Furthermore, HeLa and Hbe cells were blotted and incubated with anti-GAPDH serum to exclude any reactivity of these cell lines that might influence the results of adherence experiments (see below). Finally, all membranes were developed with 4-chloro-1-naphthol (Merck) in the presence of hydrogen peroxide.
Surface localization of M. pneumoniae GAPDH. Freshly grown M. pneumoniae cells in liquid culture were harvested as described and treated with the detergent TX-114 (1 %, Sigma) (Proft & Herrmann, 1994) . The treatment separated the TX-insoluble fraction (Triton shell) containing the majority of the membrane-associated proteins (mainly components of the cytoskeleton of the bacteria) from the cytosolic proteins. ELISA experiments were performed to test the quantitative reaction of recombinant GAPDH with rabbit antisera against the cytosolic and TX-insoluble fractions of M. pneumoniae proteins or the reaction of anti-GAPDH serum with both protein fractions. Briefly, Mikrolon plates (Greiner) were coated with 0.25 mg recombinant protein (in 0.05 M carbonate buffer; pH 9.6) or 0.5 mg protein preparation per well. After blocking with 10 % FCS in PBS, the antigen-coated wells were incubated for 1.5 h with 1 : 500-diluted sera followed by incubation with peroxidase-conjugated anti-rabbit IgG or anti-guinea pig IgG (1 : 1000). After addition of substrate (TMB Super Slow; Sigma) the reaction was stopped and the absorbance was measured at 450 nm and a reference wavelength of 620 nm. The A 450 values of the wells containing carbonate buffer without antigen (negative control) were subtracted from the test results with antigen.
Fluorescence microscopy was used to demonstrate the occurrence of surface-associated GAPDH during the adhesion process of mycoplasmas to HeLa cells. HeLa cells were seeded with 25 000 cells per well in a four-well glass slide (Nunc) and incubated at 37 uC overnight. Freshly grown M. pneumoniae culture in PPLO broth was harvested and the OD 660 was set to 0.5. HeLa cells in each chamber were infected with mycoplasmas (cell ratio 1 : 10) for 2 h at 37 uC with gentle shaking. The supernatant was discarded and the cells were fixed with 100 % methanol for 2 min at 4 uC followed by blocking with 2 % BSA for 30 min at 37 uC. Anti-GAPDH serum (1 : 250) and anti-guinea pig IgG FITC antibodies (1 : 500; Sigma) were selected for detection of mycoplasmas attached to HeLa cells. Rabbit antielongation factor G (cytosolic protein; Proft & Herrmann, 1994) , guinea pig preimmune serum (1 : 250) and anti-M. pneumoniae (whole cell) serum after subcutaneous immunization (1 : 250) served as negative and positive controls, respectively. Alternatively, the colony blot technique was used to detect GAPDH at the surface of M. pneumoniae colonies. Briefly, freshly grown M. pneumoniae cells in liquid medium were diluted with PPLO broth and spread over a Petri dish containing PPLO agar. After incubation at 37 uC for 10 days, the colonies of Petri dishes with an appropriate number of colonies (around 10 4 ) were covered for 10 min with precut pieces of nitrocellulose. The membranes were washed with PBS, blocked and treated with anti-GAPDH (1 : 200) and peroxidaseconjugated anti-guinea pig IgG (1 : 1000) as described. Antisera against the whole protein of M. pneumoniae and the cytosolic elongation factor G were used as positive and negative controls.
To assess surface-localized regions of GAPDH, mild surface proteolysis of freshly grown intact M. pneumoniae cells was carried out. Bacteria were harvested as described, diluted in PBS and adjusted to a protein concentration of 2 mg ml
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. Protein (200 mg) was incubated with different concentrations (10, 40 and 100 mg) of trypsin (Sigma) and PBS for 30 min at 37 uC. Cells were pelleted by centrifugation (10 000 g, 10 min), resuspended in 50 ml sample buffer and boiled for 5 min. Aliquots (5 ml per lane) were subjected to SDS-PAGE followed by Western blot analysis as described. Blotted trypsintreated proteins were incubated with antisera (1 : 500) against GAPDH, elongation factor G and the C-terminal part (amino acids 1287-1518 in strain M129) of the main P1 adhesin of M. pneumoniae. The reaction was developed with anti-guinea pig IgG (GAPDH, P1) and anti-rabbit IgG (elongation factor G), both at 1 : 500.
The time-dependent reactivity of the GAPDH of M. pneumoniae cells was quantified in ELISA experiments. M. pneumoniae was cultivated R. Dumke, M. Hausner and E. Jacobs in liquid medium and harvested after 2, 3, 4 and 5 days of incubation. In parallel, fresh PPLO broth was added to liquid cultures of the same inoculum and age on days 2, 3, 4 and 5 and these were harvested at the same time as the cultures without a change of medium. The protein content of the harvested bacteria was measured as described and diluted with PBS to obtain preparations with the same protein concentration to avoid an influence of differences in whole protein content on the results. TX-114 extraction was carried out with all seven cell suspensions to separate the TX-insoluble and cytosolic protein fractions of the bacteria. Individual wells of ELISA plates were coated with whole protein contents before TX extraction, and with TX-insoluble and cytosolic proteins (0.5 mg per well). Standardization of the protein content was confirmed by incubating the mycoplasma suspensions before TX preparation with an antiserum against the whole M. pneumoniae protein content (after subcutaneous immunization; 1 : 250). Polyclonal anti-GAPDH (1 : 250) was used to compare the GAPDH concentration in all protein preparations.
Binding of recombinant GAPDH to human cells. ELISA plates were coated overnight with HeLa or Hbe cells (0.5 mg per well) and increased concentrations of recombinant M. pneumoniae GAPDH were added. PBS was used as a negative control. After incubation for 2 h at room temperature and three washing steps, the amount of bound GAPDH was determined by incubating the wells with anti-GAPDH (1 : 250) and peroxidase-conjugated anti-guinea pig IgG (1 : 1000). Blocking of GAPDH binding to both cell lines was investigated by preincubation (2 h, room temperature) of GAPDH (10 mg ml 21 ) with PBS, preimmune guinea pig serum and anti-GAPDH serum at a dilution of 1 : 100 each.
Influence of anti-GAPDH on adhesion of M. pneumoniae to HeLa cells. To test the influence of the anti-GAPDH serum on the adherence of M. pneumoniae cells to HeLa cells, an in vitro adhesion inhibition assay was used as reported (Schurwanz et al., 2009) . Briefly, a freshly grown M. pneumoniae culture was harvested as described, resuspended in 1 ml PBS and sheared by passing through a 27G needle. Bacteria were labelled with FITC (Fluka), washed and resuspended to OD 660 0.44. The suspension was diluted 1 : 40 in 200 ml PBS (with 25 % PPLO medium and 10 % heat-inactivated anti-GAPDH serum) and incubated (1 h, 37 uC). HeLa cells (2.0610 5 ) were added and the suspensions were incubated at 37 uC with gentle rotation. Adherence was stopped by adding ice-cold PBS. The samples were kept on ice and immediately investigated by flow cytometry. The assay was confirmed by including a negative control (preimmune guinea pig serum) and the hyperimmune serum from a guinea pig, immunized three times subcutaneously with M. pneumoniae whole cells (positive control) in each run. Analysis was performed with a FACSCalibur flow cytometer (Becton Dickinson) and the results were evaluated with CellQuest software (version 3.3; Becton Dickinson). The mean fluorescence intensity obtained after incubation of the mycoplasmas with the preimmune guinea pig serum was set to 100 %.
To compare the quantitative reactivity of the anti-GAPDH serum with the antiserum used as positive control in the adhesion inhibition assay, 96-well plates were coated with M. pneumoniae whole protein (0.5 mg per well) and an ELISA reaction was performed with both 1 : 250 diluted antisera and 1 : 1000 diluted peroxidase-conjugated anti-guinea pig IgG.
Interaction of recombinant GAPDH of M. pneumoniae with human fibrinogen. Human fibrinogen (Sigma; 1 mg ml 21 ) was separated by SDS-PAGE, stained with Coomassie blue or blotted as described. The membrane was incubated with recombinant GAPDH of M. pneumoniae (10 mg ml 21 ) overnight at 4 uC with gentle agitation. Blotted human fibrinogen was treated in parallel with PBS alone as a negative control. After washing the membranes three times for 10 min with PBS, M. pneumoniae GAPDH antiserum (1 : 500) was added, followed by incubation with peroxidase-conjugated antiguinea pig IgG (1 : 1000). To confirm the influence of the specific serum on binding of recombinant GAPDH, increasing concentrations (0-2 mg ml 21 ) of human fibrinogen were used to coat wells of ELISA plates. Recombinant M. pneumoniae GAPDH (10 mg ml 21 ) was incubated with anti-GAPDH (1 : 100) and a preimmune guinea pig serum (1 : 100) for 2 h at room temperature. The GAPDH/serum solutions were added to the immobilized human fibrinogen (2 h, room temperature). After three washing steps with PBS/Tween 20, binding of recombinant GAPDH was determined by incubating with anti-GAPDH (1 : 500) and peroxidase-conjugated anti-guinea pig IgG (1 : 1000).
In addition, a blotted whole cell preparation of M. pneumoniae was incubated with human fibrinogen (10 mg ml 21 ) overnight at 4 uC. After three washing steps, anti-human fibrinogen (Sigma, 1 : 250) was added, followed by incubation with anti-rabbit IgG (1 : 1000). A further membrane blotted with M. pneumoniae whole protein content after incubation with PBS was treated in the same way and used as a negative control. The location of GAPDH was demonstrated by treatment of a membrane with anti-GAPDH (1 : 500) and peroxidaseconjugated anti-guinea pig IgG (1 : 1000).
RESULTS
Production of recombinant GAPDH and specific antiserum for the characterization of the M. pneumoniae mpn430 gene product
The mpn430 sequence from the three available subtypes and two variants of M. pneumoniae was amplified and fully sequenced. The results showed that the five mpn430 genes have identical sequences. In order to produce recombinant M. pneumoniae GAPDH, the mpn430 gene of strain M129 was amplified and its single TGA was exchanged by MMR as confirmed by sequencing. Full-length GAPDH was expressed in E. coli BL21(DE3), purified under denaturing conditions using Ni-nitrilotriacetic acid columns, and concentrated. Coomassie staining of SDS-PAGE-separated eluted protein extract resulted in strong bands with a molecular mass of around 37 kDa (data not shown). Diluted recombinant protein was used to produce a GAPDH-specific guinea pig polyclonal antiserum. Blotted recombinant GAPDH reacted with anti-pentahistidine antibodies and the anti-GAPDH serum (data not shown). In contrast, no specific anti-GAPDH antibodies were detected, neither in hyperimmune sera of three times infected or immunized guinea pigs nor in sera of patients with confirmed specific antibody responses to an M. pneumoniae infection. Cross-reactivity of recombinant M. pneumoniae GAPDH with anti-human GAPDH serum was excluded (identity of human GAPDH with M. pneumoniae GAPDH: 44 %). Using whole cell preparations as antigen, the anti-GAPDH serum reacted exclusively with an M. pneumoniae protein with a molecular mass of about 37 kDa (data not shown).
Localization of GAPDH in M. pneumoniae
In ELISA experiments, recombinant GAPDH reacted with the rabbit antiserum raised against the cytosolic fraction of the M. pneumoniae proteins and even more strongly with the antiserum derived from the TX-insoluble bacterial proteins (Fig. 1a) . The result was confirmed by using both protein fractions as antigens for the immunological reaction of polyclonal guinea pig anti-GAPDH serum. In contrast, A 450 values of around 0.3 were obtained with the TX-soluble phase of the protein fractionation (data not shown). Furthermore, Fig. 1(b) shows the presence of surface-located GAPDH on M. pneumoniae attached to HeLa cells after detection with anti-GAPDH as primary antibody and FITC-labelled anti-guinea pig IgG as secondary antibody. The negative control (antiserum against the cytoplasmic elongation factor G) resulted in no visible signal. To further confirm the surface localization of GAPDH, we carried out colony blot experiments with 10-day-old agar cultures incubated with anti-whole protein serum and anti-GAPDH serum (Fig. 1c) . Both sera reacted strongly with the M. pneumoniae colonies, whereas no signals were obtained after using the antiserum against the elongation factor G. To prove the occurrence of surface-exposed regions of M. pneumoniae GAPDH, mycoplasma cells were treated with trypsin. Western blot analysis revealed a concentration-dependent pattern of the three proteins tested (data not shown). The surface-located part of the membrane-spanning adhesin P1, near the C terminus (Schurwanz et al., 2009) , was cleaved after treatment with 10 and 40 mg trypsin ml 21 and no signal was obtained using 100 mg trypsin ml
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. The cytosolic elongation factor G showed the first cleavage fragment in the presence of 100 mg trypsin ml
, indicating a loss of the bacterium's membrane integrity. In contrast, GAPDH was not digested when using up to 100 mg trypsin ml 21 , suggesting that the surface-exposed part of the protein is not accessible to trypsin.
Daily exchange of PPLO broth of liquid cultures of M. pneumoniae influenced the concentration of GAPDH, both in the cytosol and at the surface of the bacterium compared with cultures without a change of medium (Fig. 2) . Adjustment of the whole protein content of mycoplasma cells obtained after cultivation over 2-5 days to the same concentration resulted in comparable A 450 values of the different antigen preparations after incubation with guinea pig serum against M. pneumoniae whole protein. In contrast, ELISA reactions of the whole bacterial cells with anti-GAPDH serum showed an increase of the A 450 in the cultures with a change of medium during the incubation period whereas the GAPDH concentration decreased in cultures without addition of fresh PPLO broth (Fig. 2a) .
Optical density values measured with the concentrated (100 : 1) supernatants of the cultures remained below 0.3, suggesting that GAPDH is not released into the medium (data not shown). The relation of the OD 450 values for the GAPDH portion in the TX-insoluble and cytosolic fractions of the M. pneumoniae proteins remains nearly constant in most cases, with a higher percentage of GAPDH in the membrane-associated protein fraction (Fig. 2b) . The highest ratio between TX-insoluble and cytosolic GAPDH was found in the 2-day-old culture, indicating early transport of the protein to the surface of the bacterium. With a semiquantitative ELISA, using tenfold dilutions of recombinant GAPDH with a known protein concentration, the percentage of GAPDH in the TXinsoluble protein fraction was assessed at around 70 % of the total GAPDH content of the cell preparation from day 2 after the start of culture (data not shown). The finding that there was a high concentration of surface-localized GAPDH in the early culture period followed by decreased occurrence of the protein during further incubation was confirmed by fluorescence experiments using rabbit antiserum against the TX-insoluble fraction and guinea pig anti-GAPDH serum in parallel. Proteins were detected with a TRITC-labelled anti-rabbit IgG antibody and FITClabelled anti-guinea pig serum as described. The intensity of the FITC fluorescence on day 1 of the culture was comparable to the TRITC signal. Beginning on day 2, a decrease in the intensity of the GAPDH-dependent FITC fluorescence was found with extensive disappearance of the signal on day 4, in contrast with stable TRITC fluorescence over the whole incubation period (data not shown).
Influence of anti-GAPDH serum on adhesion of M. pneumoniae to HeLa cells
In ELISA experiments, recombinant GAPDH of M. pneumoniae bound to both immobilized human HeLa and Hbe cells in a concentration-dependent manner (Fig.  3a) . Binding was significantly reduced after pretreatment of the protein with anti-GAPDH serum before the interaction with HeLa and Hbe cells compared with the effect of a guinea pig preimmune serum (Fig. 3b) . Nevertheless, using the FACS-based adhesion inhibition assay, anti-GAPDH serum was not found to have any influence on the adherence of M. pneumoniae cells to HeLa cells (Fig. 4) . Compared with the cell-adhered bacteria after preincubation with the preimmune serum (set to 100 %), around 94 % of mycoplasmas preincubated with anti-GAPDH serum were found to be attached to HeLa cells. As a positive control for adhesion inhibition, the adherence of bacteria after contact with an antiserum against the whole cell preparation of M. pneumoniae was reduced to 1 %, which is in accordance with the results of our previous investigations (Schurwanz et al., 2009) . To test the antibody reaction of the anti-whole cell and the anti-GAPDH serum against the mycoplasma suspension used in the adhesion inhibition assay, an ELISA was carried out and resulted in comparable A 450 values (inset on Fig. 4) . Thus, the difference between the two antisera regarding the adhesion inhibition of mycoplasmas to HeLa cells cannot be attributed to greatly different antibody levels.
Interaction of recombinant GAPDH with human fibrinogen
Binding studies in Western blot experiments using immobilized human fibrinogen incubated with recombinant GAPDH of M. pneumoniae were performed to investigate the possible interaction between the two proteins. Bound GAPDH was detected with polyclonal anti-GAPDH at molecular masses around 50 kDa corresponding to the light chains of fibrinogen, as confirmed by Coomassie staining (Fig. 5a) . No cross-reaction with blotted fibrinogen preincubated with PBS was observed. Changing the immobilized binding partner by blotting whole cell preparations of M. pneumoniae and detecting bound human fibrinogen with an anti-human fibrinogen polyclonal serum confirmed the previous finding. Fibrinogen interacts mainly with a protein of around 37 kDa matching the target of the anti-GAPDH serum (Fig. 5b) . The serum was not found to react with the M. pneumoniae protein(s).
To further characterize the interaction between GAPDH and human fibrinogen quantitatively, we monitored the binding process by ELISA (Fig. 5c ). Plates were coated with increasing concentrations of fibrinogen. Detection of recombinant GAPDH (10 mg ml
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) preincubated with preimmune guinea pig serum resulted in increased A 450 values, indicating that the interaction was concentrationdependent. Addition of recombinant GAPDH preincubated with anti-GAPDH led to significantly (t-test, P,0.05) reduced optical densities over the entire concentration range of fibrinogen used for coating.
DISCUSSION
According to current knowledge, the mucosal pathogen M. pneumoniae uses a limited but effective repertoire of mechanisms to initiate an infection in the respiratory tract of humans and to organize colonization of the host. These mechanisms include the formation of a highly differentiated complex of adhesins that occur exclusively in mycoplasmas and the expression of cell-affecting substances. A further aspect in pathogen-host interaction might be the surface exposure of predicted anchorless glycolytic enzymes like GAPDH that occur primarily in the cytosol of the mycoplasma cell. The diverse activities of these proteins are well documented in many pathogenic or opportunistic micro-organisms, including members of the class Mollicutes. Particularly under the conditions of the minimized genome of these bacteria, multiple protein functions are a way of maximizing the effect of the limited genetic information (Alvarez et al., 2003) . As opposed to other firmicutes, genes encoding glycolytic enzymes are highly distributed on the chromosome of M. pneumoniae and GAPDH forms a cluster with phosphoglycerate kinase only (Dutow et al., 2010) . In contrast with microorganisms such as N. meningitidis (Tunio et al., 2010a) or E. coli (Egea et al., 2007) , the genome of M. pneumoniae contains a single copy of a GAPDH sequence (Dandekar et al., 2000) . Furthermore, no differences in the GAPDHencoding gene were found in the available three subtypes and two variants of M. pneumoniae showing variable sequences in adhesin regions (Dumke et al., 2010) . This fact confirms the results of our previous study, demonstrating that M. pneumoniae strains are very homogeneous from a genetic point of view (Dumke et al., 2003) . The GAPDH of M. pneumoniae (Mpn430) is a basic protein (pI 8.68) consisting of 338 amino acids with a molecular mass of 36.8 kDa, showing no predicted signal sequence or membrane-spanning motifs. This is in agreement with the characteristics of GAPDH in other micro-organisms (Pancholi & Chhatwal, 2003) . The anchoring of surfaceassociated metabolic enzymes in the cell wall or in the cell membrane (in Mollicutes) remains an unsolved problem. The same is true for the protein transport mechanism at the cell surface, since the classical secretion signals are absent, indicating a non-classical secretion pathway (Bendtsen et al., 2005) . Using different methods, GAPDH of M. pneumoniae can be assumed to be associated with the surface of the bacteria. The protein was detected in the TX-insoluble phase of the M. pneumoniae proteins, which is consistent with the data from a previous study (Regula et al., 2001) . The results of a semiquantitative ELISA with recombinant GAPDH of known concentration confirmed that between 50 and 70 % of all GAPDH was found in the TX-insoluble protein fraction. Alvarez et al. (2003) reported that 10 % of the total GAPDH of M. genitalium was membrane-associated, but used a different method for membrane purification from the one used in the present study. Nevertheless, the data confirm the occurrence of remarkable amounts of GAPDH in the membrane-associated protein fraction of the bacteria, especially in early stages of the culture (2 days). Furthermore, the concentration of GAPDH at the surface and in the cytosol of bacteria in liquid medium is strongly influenced by the nutrient conditions, as indicated by the different results obtained with and without addition of fresh glucose-containing PPLO broth. Factors described as important for the extra-cytosolic concentration of GAPDH in other micro-organisms are temperature, starvation (Delgado et al., 2003) and pH (Wilkins et al., 2003) . During the further culture period, the relationship between surface and cytosolic GAPDH remains nearly constant, suggesting constant transport of the protein to the bacterial cell membrane. Despite the occurrence of more than 40 cleavage sites for trypsin (www.expasy.ch/ tools/peptidecutter/), proteolytic digestion experiments resulted in a lack of accessible surface-exposed M. pneumoniae GAPDH, whereas M. genitalium GAPDH (82 % identity) was described as trypsin-sensitive (Alvarez et al., 2003) . A clear antibody response to recombinant GAPDH was not detected either in hyperimmune sera of intranasally infected or subcutaneously immunized guinea pigs, or in sera of patients with serologically confirmed M. pneumoniae infection. Taken together, the data indicate the surface exposure of a very limited and non-antigenic part of the protein. Furthermore, experimental data support the importance for the binding behaviour of small sequence differences in mycoplasma proteins. Balasubramanian et al. (2009) demonstrate the nonfibronectin-binding property of elongation factor Tu of M. genitalium, as opposed to the nearly identical (96 % identity) but fibronectin-binding homologue in M. pneumoniae. It was hypothesized that the different binding behaviour of similar proteins to human ECM proteins is based on the existence of different forms of the molecule (Dallo et al., 2002; Barbosa et al., 2006; Egea et al., 2007) , which could influence basic aspects of pathogenesis, like tissue tropism. All three glycolytic enzymes described up to now in M. pneumoniae that act as binding partners of human ECM components are characterized as phosphoproteins , providing an opportunity to regulate the moonlighting role of these proteins via phosphorylation.
The dual role of glycolytic enzymes in metabolism and pathogenesis seems advantageous especially for microorganisms with a reduced genetic repertoire such as mycoplasmas. Since the function of different glycolytic enzymes as binding partners of human ECM proteins has so far been confirmed for at least three species (M. pneumoniae, M. genitalium and M. fermentans; Alvarez et al., 2003; Yavlovich et al., 2007) , the mechanism can be suggested for further members of the class Mollicutes. On the other hand, the occurrence of surface-associated glycolytic enzymes that play a role in the pathogenesis of other, phylogenetically unrelated micro-organisms, including Gram-positive and Gram-negative bacteria and fungal or parasite species that infect different sites of the human body, indicates a common adaptation that has developed in different host-pathogen interactions. The defined binding partners of GAPDH differed in the species investigated. Fibrinogen and plasminogen were found in E. coli (Egea et al., 2007) , fibronectin, plasminogen and laminin in T. vaginalis (Lama et al., 2009) , fibronectin, type I collagen and laminin in P. brasiliensis (Barbosa et al., 2006) , fibronectin and laminin in C. albicans (Gozalbo et al., 1998) , and multiple factors in Streptococcus pneumoniae (Pancholi & Fischetti, 1992; Bergmann et al., 2004) . The precise mechanisms of these interactions are not fully understood. Nevertheless, the inhibition of the export of GAPDH to the surface of group A Streptococcus bacteria affects the virulence properties (Boël et al., 2005) . Two recent studies confirmed the importance of GAPDH for the pathogenesis of Staphylococcus aureus infections (Purves et al., 2010) and the significant reduction of the adhesion of a GapA mutant of N. meningitidis to human cells in comparison with wild-type strains (Tunio et al., 2010a) . According to the widespread occurrence of the phenomenon in microbes which cause clinically relevant infections or live as commensals, it can be speculated that the expression of GAPDH on the surface of the microorganisms indicates an advantage in the interaction with the host. Binding to ECM proteins can provide access to or maintenance in locations in the host which are beneficial for the micro-organism. Here, the lack of inhibition of the adherence process of M. pneumoniae to HeLa cells by polyclonal anti-GAPDH serum suggests a limited influence on the primary adhesion process, which is mediated mainly by the characterized adhesins of the tip structure. After this first step, the gliding motility of the mycoplasmas (Miyata, 2010) allows movement to deeper layers of the respiratory epithelium, where higher concentrations of ECM proteins provide the bacterium with a nutrient-rich environment and/or partial protection from the host's immune response (Madureira et al., 2007) .
The occurrence of more than a single glycolytic enzyme in a micro-organism that binds to defined human ECM proteins (in M. pneumoniae: GAPDH, PDH) and the detection of more than one mycoplasma protein interacting with a given ECM protein (in M. pneumoniae: binding of PDH and elongation factor Tu to human fibronectin; Dallo et al., 2002) suggest the existence of a complex network of binding partners in the host-pathogen interaction. Future studies should investigate if the microbial proteins involved in the process might be transported to the cell surface in a time-dependent way. This will also include characterization of further proteins that play a role in the network. For example, the interaction of M. pneumoniae enolase (Mpn606) with human plasminogen was predicted (Chumchua et al., 2008) but not proven experimentally. The reaction of human fibrinogen with blotted whole proteins of M. pneumoniae (Fig. 5b) indicated the existence of additional mycoplasma proteins (around 40 kDa) interacting with fibrinogen. Furthermore, a recent study confirms that the glycolytic enzyme fructose-1,6-bisphosphate aldolase (Mpn025 in M. pneumoniae) is important in the adhesion process of N. meningitidis to human cells (Tunio et al., 2010b) .
In summary, the findings of the present study offer new insights into the role of glycolytic enzymes in the pathogenesis of infections due to cell wall-less bacteria with a reduced genome such as M. pneumoniae. Here, we demonstrated for the first time to our knowledge that the GAPDH of these micro-organisms is exposed on the cell surface depending on the nutrient supply and that the surface-localized enzyme interacts with human fibrinogen. The results add a further piece to the puzzle explaining the complex mechanisms in the interaction between M. pneumoniae and the human host.
